CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Dec. 28, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that it has entered...
Hence then, the article about harbour biomed enters into long term strategic collaboration with lannacheng to advance next generation radionuclide drug conjugates was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates )
Also on site :
- Reported tornado rips roofs off multiple homes in central Illinois
- Crews respond to large fire at Denny Hamlin's parents' house in Stanley: Sources
- The Starmer regime is turning Britain into a police state